5 withdrawn. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Withdrawn 5 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Cardiovascular Abnormalities: new trials by email Literature Review of Cardiovascular Abnormalities trials Research Report on Cardiovascular Abnormalities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia TER-1754, Placebo - Hereditary Hemorrhagic Telangiectasia (HHT) | Phase 1 | Withdrawn | Terremoto Biosciences Inc. | 2025-12-15 | 2026-04-13 | |
| Nitric Oxide During CPB to Reduce AKI in Neonates NO gas delivered during cardiac surgery, placebo gas delivered during cardiac surgery - Congenital Heart Disease, Acute Kidney Injury | Phase 1 | Withdrawn | Fabio Savorgnan | 2021-10-01 | 2021-12-01 | |
| Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow IV L-carnitine - Heart Septal Defects, Ventricular, Atrioventricular Septal Defect | Phase 1 | Withdrawn | University of California, San Francisco | 2014-12-01 | 2020-05-06 | |
| Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) Ranibizumab - Hereditary Hemorrhagic Telangiectasia (HHT), Nosebleeds | Phase 1 | Withdrawn | University of California, San Diego | 2011-07-01 | 2013-04-29 | |
| Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients Iloprost, Placebo - Pulmonary Hypertension, Neonatal Hypoxic Respiratory Failure | Phase 1 / Phase 2 | Withdrawn | Seattle Children's Hospital | 2009-09-01 | 2015-01-19 |
Heart Defects, Congenital (3) · Epistaxis (2) · Telangiectasia, Hereditary Hemorrhagic (2) · Acute Kidney Injury (1) · Anemia (1) · Arteriovenous Malformations (1) · Atrioventricular Septal Defect (1) · Heart Septal Defects, Ventricular (1) · Hypertension, Pulmonary (1) · Persistent Fetal Circulation Syndrome (1) · Respiratory Distress Syndrome (1)
Cardiovascular Diseases (5) · Congenital Abnormalities (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Heart Diseases (3) · Respiratory Tract Diseases (3) · Vascular Diseases (3) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhage (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Nose Diseases (2) · Otorhinolaryngologic Diseases (2) · Pathologic Processes (2)
Carnitine (1) · Iloprost (1) · Ranibizumab (1)
Fabio Savorgnan (1) · Seattle Children's Hospital (1) · Terremoto Biosciences Inc. (1) · University of California, San Diego (1) · University of California, San Francisco (1)
United States (3)
Delphine Yung, MD (1) · Fabio Savorgnan, MD (1) · Jeffrey Fineman, MD (1) · Terence Davidson, M.D. (1)